Alset AE - Search Results

1

Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture.

Shields CL, Alset AE, Boal NS, Casey MG, Knapp AN, Sugarman JA, Schoen MA, Gordon PS, Douglass AM, Sioufi K, Say EA, Shields JA. Shields CL, et al. Among authors: alset ae. Am J Ophthalmol. 2017 Jan;173:106-133. doi: 10.1016/j.ajo.2016.09.034. Epub 2016 Oct 8. Am J Ophthalmol. 2017. PMID: 27725148

2

Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in Children.

Shields CL, Sioufi K, Alset AE, Boal NS, Casey MG, Knapp AN, Sugarman JA, Schoen MA, Gordon PS, Say EA, Shields JA. Shields CL, et al. Among authors: alset ae. JAMA Ophthalmol. 2017 Mar 1;135(3):215-224. doi: 10.1001/jamaophthalmol.2016.5544. JAMA Ophthalmol. 2017. PMID: 28125759

3

Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.

Shields CL, Jorge R, Say EA, Magrath G, Alset A, Caywood E, Leahey AM, Jabbour P, Shields JA. Shields CL, et al. Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr;5(2):97-103. doi: 10.1097/APO.0000000000000172. Asia Pac J Ophthalmol (Phila). 2016. PMID: 26765038 Free article.

4

Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.

Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA. Shields CL, et al. Among authors: alset ae. J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):275-84. doi: 10.3928/01913913-20160719-04. Epub 2016 Aug 4. J Pediatr Ophthalmol Strabismus. 2016. PMID: 27486728

5

The role of oral steroids in the treatment of photodynamic therapy-associated exudative maculopathy, a case report and review of the literature.

Sumnicht AJ, Chalam KV, Alset AE, Sierpina DI. Sumnicht AJ, et al. Among authors: alset ae. Photodiagnosis Photodyn Ther. 2021 Sep;35:102390. doi: 10.1016/j.pdpdt.2021.102390. Epub 2021 Jun 11. Photodiagnosis Photodyn Ther. 2021. PMID: 34119709 Review.

6

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.

Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.

7

Phthiriasis Palpebrarum Treated with Oral Ivermectin.

Dredge JH, Winter TW, Alset AE. Dredge JH, et al. Among authors: alset ae. Ophthalmology. 2019 Jun;126(6):791. doi: 10.1016/j.ophtha.2019.02.024. Ophthalmology. 2019. PMID: 31122358 No abstract available.

8

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.

Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.

9

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.

Hutton DW, Glassman AR, Liu D, Sun JK; DRCR Retina Network. Hutton DW, et al. JAMA Ophthalmol. 2023 Mar 1;141(3):268-274. doi: 10.1001/jamaophthalmol.2022.6142. JAMA Ophthalmol. 2023. PMID: 36729431 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page